08/09/2025
๐๐๐จ๐ฃ๐ฅ๐ข๐๐๐ก ๐๐ก๐ ๐ฃ๐๐ฅ๐๐๐๐ง๐๐ ๐ข๐๐ ๐๐ฌ ๐๐๐๐ฃ ๐ช๐ข๐ฅ๐ฆ๐๐ก ๐ข๐จ๐ฅ ๐๐ก๐ง๐๐๐๐ข๐ง๐๐ ๐ฅ๐๐ฆ๐๐ฆ๐ง๐๐ก๐๐
We often trust ๐ถ๐ฏ๐๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐ป and ๐ฝ๐ฎ๐ฟ๐ฎ๐ฐ๐ฒ๐๐ฎ๐บ๐ผ๐น to ease our pain, but startling new research from the University of South Australia reveals that these everyday medicines may be secretly powering one of humanityโs deadliest threats: antibiotic resistance.
Researchers tested how ๐๐ด๐ค๐ฉ๐ฆ๐ณ๐ช๐ค๐ฉ๐ช๐ข ๐ค๐ฐ๐ญ๐ช (๐. ๐ค๐ฐ๐ญ๐ช), bacteria often responsible for urinary tract and bloodstream infections, responded when exposed to the antibiotic ciprofloxacin alongside the widely used pain relievers. The findings were alarming: the bacteria developed higher mutation rates and became resistant not only to ciprofloxacin but also to several other antibiotic classes, showing a cross-resistance effect.
This suggests that ๐ป๐ผ๐ป-๐ฎ๐ป๐๐ถ๐ฏ๐ถ๐ผ๐๐ถ๐ฐ ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ ๐บ๐ฎ๐ ๐ถ๐ป๐๐ฒ๐ฟ๐ณ๐ฒ๐ฟ๐ฒ ๐๐ถ๐๐ต ๐ฎ๐ป๐๐ถ๐ฏ๐ถ๐ผ๐๐ถ๐ฐ๐ ๐ฎ๐ ๐๐ต๐ฒ ๐ฐ๐ฒ๐น๐น๐๐น๐ฎ๐ฟ ๐น๐ฒ๐๐ฒ๐น, possibly by stressing bacterial DNA repair systems or altering metabolic pathways. The study is especially relevant in aged-care facilities, where residents often take multiple medications.
While doctors arenโt advising people to stop using these painkillers, the research underscores the urgent need to better understand drugโdrug interactions in fighting antibiotic resistance.
๐ ๐ฐ๐ถ ๐ฎ๐ข๐บ ๐ค๐ฉ๐ฆ๐ค๐ฌ ๐ต๐ฉ๐ฆ ๐ญ๐ช๐ฏ๐ฌ ๐ต๐ฐ ๐ต๐ฉ๐ฆ ๐ง๐ถ๐ญ๐ญ ๐ข๐ณ๐ต๐ช๐ค๐ญ๐ฆ ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ค๐ฐ๐ฎ๐ฎ๐ฆ๐ฏ๐ต ๐ด๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ.
